American International Group, Inc. Oncorus, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.04 - $1.86 $10,545 - $18,860	-10,140 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.44 - $5.62 $1,028 - $4,012	-714 Reduced 6.58%	10,140 $18,000
Q4 2021 Feb 11, 2022	SELL	$5.03 - $11.63 $1,629 - $3,768	-324 Reduced 2.9%	10,854 $57,000
Q3 2021 Nov 12, 2021	SELL	$9.29 - $14.27 $2,471 - $3,795	-266 Reduced 2.32%	11,178 $104,000
Q2 2021 Aug 13, 2021	BUY	$13.3 - $17.3 $94,031 - $122,311	7,070 Added 161.64%	11,444 $158,000
Q1 2021 May 07, 2021	BUY	$11.89 - $35.55 $6,230 - $18,628	524 Added 13.61%	4,374 $61,000
Q4 2020 Feb 12, 2021	BUY	$15.0 - $35.15 $57,750 - $135,327	3,850 New	3,850 $124,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.